All Podcasts – Lifestyle
Author:
CAMP4 Therapeutics
CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
April 28, 2026
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 17, 2026
CAMP4 Appoints Michael MacLean to its Board of Directors
March 24, 2026
CAMP4 to Participate in Upcoming Investor Conferences
March 6, 2026
CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
March 6, 2026